TY  - JOUR
AU  - García Pérez, Javier
AU  - Portolés Pérez, Antonio
AU  - Pérez Ingidua, Carla
AU  - Lora Pablos, David
AU  - Gómez De La Cámara, Agustín Ramón
AU  - Díez Fuertes, Francisco
AU  - Ascaso del Río, Ana
PY  - 2024
DO  - 10.1016/j.isci.2024.110728
SN  - 2589-0042
UR  - https://hdl.handle.net/20.500.14352/116260
T2  - iScience
AB  - SummaryCombiVacS study has demonstrated a strong immune response of the heterologous ChAdOx1-S/BNT162b2 vaccine combination. The primary outcomes of the study were to assess the humoral immune response against SARS-CoV-2, 28 days after a third dose of...
LA  - eng
PB  - Elsevier
TI  - Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants
TY  - journal article
VL  - 27
ER  -